Hinge Health, Inc. (HNGE) - Dilution Analysis
Visualizing historical and potential share dilution over time
Dilution Analysis
Risk Assessment Details
Summary
HNGE currently has 54.7M outstanding shares. with moderate dilution risk from 15.7M authorized shares representing 28.8% potential dilution. The company has significantly diluted shareholders by 151.29% over the past 2 years, indicating aggressive capital raising.
Share Structure Timeline
Historical Data Points
| Date | Event | Outstanding | Supply |
|---|---|---|---|
| May 07, 2026 |
10-Q filing | 54.7M shares outstanding |
55M | 16M |
| Nov 07, 2025 |
10-Q filing | 37.9M shares outstanding |
38M | 16M |
| Aug 11, 2025 |
10-Q filing | 27.2M shares outstanding |
27M | 16M |
| May 16, 2025 |
S-1/A filing: This S-1/A filing includes information about the company's offering of Class A common stock, Class B common stock, and Series E preferred stock. It details the number of shares offered by the company and selling stockholders, as well as the total shares outstanding after the offering. It also discusses the use of proceeds, voting rights, and other rights of the different classes of stock. |
16M | 16M |
| May 13, 2025 |
S-1/A filing: This S-1/A filing registers the offering of Class A common stock by the company and selling stockholders, along with an option for underwriters to purchase additional shares. |
78M | 16M |
| May 05, 2025 |
S-1/A filing: This is an S-1/A filing related to an offering of Class A common stock by the company and selling stockholders, including an option to purchase additional shares. |
N/A | 0 |
| Apr 07, 2025 |
S-1/A filing: This is an S-1/A filing for an initial public offering involving Class A common stock offered by the company and selling stockholders, including an option to purchase additional shares. |
N/A | 0 |
| Mar 10, 2025 |
S-1 filing: This is an S-1 filing for an initial public offering of Class A common stock, with additional offerings by selling stockholders and an option to purchase additional shares. The filing also discusses outstanding shares of Class B common stock and Series E preferred stock, as well as voting rights and use of proceeds. |
N/A | 0 |